(Q44315644)

1 July 2019

title

Validation of a prediction algorithm for progression to advanced macular degeneration subtypes (English)

1 reference

1 July 2019

1 reference

4

Bernard Rosner

1 reference

1 July 2019

author name string

Johanna M Seddon

series ordinal

1

1 reference

1 July 2019

Robyn Reynolds

series ordinal

2

1 reference

1 July 2019

Yi Yu

series ordinal

3

1 reference

1 July 2019

language of work or name

English

0 references

publication date

1 April 2013

1 reference

1 July 2019

published in

JAMA Ophthalmology

1 reference

1 July 2019

volume

131

1 reference

1 July 2019

issue

4

1 reference

1 July 2019

page(s)

448-455

1 reference

1 July 2019

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

cites work

1 reference

12 December 2020

Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio

1 reference

12 December 2020

A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions

1 reference

12 December 2020

Complement factor H variant increases the risk of age-related macular degeneration

1 reference

12 December 2020

Complement factor H polymorphism and age-related macular degeneration

1 reference

12 December 2020

Complement factor H polymorphism in age-related macular degeneration

1 reference

12 December 2020

The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences

1 reference

12 December 2020

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

1 reference

12 December 2020

Susceptibility genes for age-related maculopathy on chromosome 10q26

1 reference

12 December 2020

Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk

1 reference

12 December 2020

Evaluation of the clinical age-related maculopathy staging system

1 reference

12 December 2020

Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

1 reference

12 December 2020

CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration

1 reference

12 December 2020

Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration

1 reference

12 December 2020

HTRA1 promoter polymorphism in wet age-related macular degeneration

1 reference

12 December 2020

A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration

1 reference

12 December 2020

Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration

1 reference

12 December 2020

Complement C3 variant and the risk of age-related macular degeneration

1 reference

12 December 2020

Variation in complement factor 3 is associated with risk of age-related macular degeneration

1 reference

12 December 2020

A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration

1 reference

12 December 2020

Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models

1 reference

12 December 2020

Variation near complement factor I is associated with risk of advanced AMD

1 reference

12 December 2020

Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables

1 reference

12 December 2020

Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes

1 reference

12 December 2020

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)

1 reference

12 December 2020

Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial

1 reference

12 December 2020

Serum Lipid Biomarkers and Hepatic Lipase Gene Associations with Age-Related Macular Degeneration

1 reference

12 December 2020

ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration

1 reference

12 December 2020

Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration

1 reference

12 December 2020

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration

1 reference

12 December 2020

Risk assessment model for development of advanced age-related macular degeneration

1 reference

12 December 2020

Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors

1 reference

12 December 2020

Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models

1 reference

12 December 2020

Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes

1 reference

12 December 2020

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

12 December 2020

Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test

1 reference

12 December 2020

10.1001/JAMAOPHTHALMOL.2013.2578

Identifiers

DOI

1 reference

1 July 2019

PMC publication ID

6547827

1 reference

1 July 2019

PubMed publication ID

23411794

1 reference

1 July 2019